Issue 2/2005
Content (10 Articles)
Editorial
Friction-cost method as an alternative to the human-capital approach in calculating indirect costs
Howard Birnbaum
Leading Article
The diffusion of health economics knowledge in Europe
Gérard de Pouvourville, Philippe Ulmann, John Nixon, Stéphanie Boulenger, Julie Glanville, Michael Drummond
Leading Article
The case for stratified cost-effectiveness analysis by baseline health-related QOL
Joseph Schaafsma
Original Research Article
Cost effectiveness of treating low HDL-cholesterol in the primary prevention of coronary heart disease
Joel W. Hay, Kimberly L. Sterling
Original Research Article
Providing systematic guidance in pharmacoeconomic guidelines for analysing costs
Philip Jacobs, Arto Ohinmaa, Bruce Brady
Original Research Article
Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder
José-Luis Fernandez, Stuart Montgomery, Clément Francois
Original Research Article
Cost-minimisation analysis of sivelestat for acute lung injury associated with systemic inflammatory response syndrome
Naoki Aikawa, Seitaro Fujishima, Makoto Kobayashi, Shozo Matsuoka, Taira Abiru
Original Research Article
The impact of anaemia and its treatment on employee disability and medical costs
Ernst Berndt, William Crown, Joel Kallich, Stacey Long, Xue Song, Gary H. Lyman